Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model

Brain

Volumn 138, Issue 11, 2015, Pages 3159-3167

  Wright, Sukhvir ^a   Hashemi, Kevan ^b   Stasiak, Lukasz ^a   Bartram, Julian ^a   Lang, Bethan ^a   Vincent, Angela ^a   Upton, A Louise ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OpenSource Instruments Inc   (United States)

Author keywords

antibody; mouse electroencephalography; NMDAR; seizures

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PENTETRAZOLE; AUTOANTIBODY; CONVULSANT AGENT; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS SOFTWARE; ELECTROCARDIOGRAPH ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPH; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; EXPERIMENTAL MOUSE; FEMALE; HIPPOCAMPUS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DENSITY; SCORING SYSTEM; SEIZURE; SEIZURE SUSCEPTIBILITY; SPIKE; SYNAPSE; TISSUE DISTRIBUTION; VIDEORECORDING; ANIMAL; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN; C57BL MOUSE; COMPLICATION; DISEASE MODEL; ELECTROENCEPHALOGRAPHY; HUMAN; IMMUNOLOGY; METABOLISM; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; SEIZURES;

ANIMALS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; BRAIN; CONVULSANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; PENTYLENETETRAZOLE; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

EID: 84947753367     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv257     Document Type: Article

References (28)

1. Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013; 54: 1028-35.
2. Chang P, Hashemi KS, Walker MC. A novel telemetry system for recording EEG in small animals. J Neurosci Methods 2011; 201: 106-15.
3. Chiu C, Miller MC, Caralopoulos IN, Worden MS, Brinker T, Gordon ZN, et al. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CNS 2012; 9: 3.
4. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
5. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-8.
6. Dhir A, Naidu PS, Kulkarni SK. Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice. Clin Exp Pharmacol Physiol 2005; 32: 574-84.
7. Ferraro TN, Golden GT, Snyder R, Laibinis M, Smith GG, Buono RJ, et al. Genetic influences on electrical seizure threshold. Brain Res 1998; 813: 207-10.
8. Ferraro TN, Golden GT, Smith GG, St Jean P, Schork NJ, Mulholland N, et al. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 1999; 19: 6733-9.
9. Fukushima F, Nakao K, Shinoe T, Fukaya M, Muramatsu S, Sakimura K, et al. Ablation of NMDA receptors enhances the excitability of hippocampal CA3 neurons. PloS One 2009; 4: e3993.
10. Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, et al. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl Psychiatry 2012; 2: e142.
11. Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, et al. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 1996; 16: 2034-43.
12. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-75.
13. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, et al. Nmethyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 2010; 133(Pt 6): 1655-67.
14. Jantzen SU, Ferrea S, Wach C, Quasthoff K, Illes S, Scherfeld D, et al. In vitro neuronal network activity in NMDA receptor encephalitis. BMC Neurosci 2013; 14: 17.
15. Li Q, Clark S, Lewis DV, Wilson WA. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 2002; 22: 3070-80.
16. Luttjohann A, Fabene PF, van Luijtelaar G. A revised Racine's scale for PTZ-induced seizures in rats. Physiol Behav 2009; 98: 579-86.
17. Manto M, Dalmau J, Didelot A, Rogemond V, Honnorat J. In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis 2010; 5: 31.
18. Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012; 135: 1606-21.
19. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 76: 108-19.
20. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, et al. Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 2009; 66: 458-64.
21. Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E, et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 2014; 138: 94-109.
22. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012; 69: 582-93.
23. Rajabzadeh A, Bideskan AE, Fazel A, Sankian M, Rafatpanah H, Haghir H. The effect of PTZ-induced epileptic seizures on hippocampal expression of PSA-NCAM in offspring born to kindled rats. J Biomed Sci 2012; 19: 56.
24. Suleiman J, Wright S, Gill D, Brilot F, Waters P, Peacock K, et al. Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 2013; 54: 2091-100.
25. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-65.
26. Weiergraber M, Henry M, Krieger A, Kamp M, Radhakrishnan K, Hescheler J, et al. Altered seizure susceptibility in mice lacking the Ca(v)2. 3 E-type Ca2 + channel. Epilepsia 2006; 47: 839-50.
27. Wykes RC, Heeroma JH, Mantoan L, Zheng K, MacDonald DC, Deisseroth K, et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci Transl Med 2012; 4: 161ra52.
28. Zhang Q, Tanaka K, Sun P, Nakata M, Yamamoto R, Sakimura K, et al. Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 2012; 45: 610-15.